• 1. School of Rehabilitation Medicine, Capital Medical University, Beijing 100068, P. R. China;
  • 2. Department of Neurorehabilitation, Beijing Bo’ai Hospital, China Rehabilitation Research Centre, Beijing 100068, P. R. China;
DU Xiaoxia, Email: 364906784@qq.com
Export PDF Favorites Scan Get Citation

Post-stroke cricopharyngeal achalasia is a common swallowing disorder that significantly impacts patients’ quality of life. Traditional treatments have limited efficacy, and in recent years, botulinum toxin injections have gained widespread application due to their therapeutic effects. This method involves local injection to relax the cricopharyngeal muscle, improving swallowing function while enhancing safety and comfort, with relatively long-lasting efficacy. However, current practices lack standardised procedures and precise targeting. Future efforts should focus on optimising treatment protocols to enhance efficacy and reduce adverse reactions. This article reviews the current state of research on botulinum toxin treatment for post-stroke cricopharyngeal achalasia, with the aim of providing a basis for standardised treatment in the future.

Citation: MAO Xin’ao, DU Xiaoxia. Research progress on botulinum toxin treatment for post-stroke cricopharyngeal achalasia. West China Medical Journal, 2025, 40(7): 1166-1170. doi: 10.7507/1002-0179.202505048 Copy

Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress on immunoglobulin A nephropathy with positive anti-neutrophil cytoplasmic antibody
  • Next Article

    Research progress of coronary bioabsorbable metal stents